Encompass Health Corporation

NYSE:EHC

Medical - Care Facilities

Healthcare
$134.93 -1.95%

-$1.95 today

Market cap
$13.24B
Beta
0.59
P/E (TTM)
15.9
EPS (TTM)
$6.14
Dividend yield
0.76%
52W Low $92.77High $127.99

Volume 0.84M

Average 0.92M

EHC EBITDA Margin

EBITDA as a percentage of revenue.

Encompass Health CorporationNYSE: EHC

EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026

EBITDA Margin holds steady near 24.1%

EBITDA Margin was 24.1% in Q2 FY2026, up 0.3 pp from a year earlier. On a trailing-twelve-month basis it was 24.2%, up 1.1 pp year over year. Over 3 fiscal years it widened by 3.6 pp.

Context

  • EBITDA Margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 10 analysts of 24.0% for the fiscal year ending Dec 2026, up from 23.7% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
24.1%-1.6 pp QoQ
Last fiscal yearDec 2025
23.7%+1.6 pp YoY
LTMJun 2026
24.2%+1.1 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.3 pp-1.3 pp-1.6 pp
1 year+1.6 pp+0.3 pp-1.2 pp
3 years+3.6 pp+1.6 pp-2.1 pp
5 years+4.0 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
23.7%
Year-over-year change
+1.6pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How EHC compares with its peers on the latest reported figures

  • EHC's LTM Jun 2026 EBITDA Margin of 24.2% is the highest of the 9 companies compared; the peer median is 11.3%.
  • Its year-over-year change of +1.1 pp is the 3rd highest of 9, against a peer median of +0.2 pp.
  • Over three fiscal years its change of +3.6 pp compares with a peer median of +0.7 pp.
EHC Competitors Peer median
EBITDA Margin for EHC and competitors
Company Period LTM level YoY 3-year change
EHCEncompass Health CorporationLTM Jun 202624.2% +1.1 pp+3.6 pp
CHEChemed CorporationLTM Jun 202616.6% -1.4 pp-1.7 pp
NHCNational HealthCare CorporationLTM Sep 202613.1% +0.5 pp+7.7 pp
AVAHAveanna Healthcare Holdings Inc.LTM Oct 202613.0% +1.4 pp+40.8 pp
ADUSAddus HomeCare CorporationLTM Jun 202611.3% +0.7 pp+2.0 pp
ENSGThe Ensign Group, Inc.LTM Jun 202611.3% -0.1 pp-0.7 pp
PACSPACS Group, Inc.LTM Jun 20268.6% +2.5 pp-3.6 pp
OPCHOption Care Health, Inc.LTM Sep 20266.9% -0.5 pp-0.9 pp
PNTGThe Pennant Group, Inc.LTM Mar 20265.9% -0.7 pp+2.7 pp
Peer median (excluding EHC) 11.3%+0.2 pp+0.7 pp

Competitors are the stored peer set for EHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.01B4.35B4.8B5.37B5.94B
Cost of Revenue2.31B2.6B2.82B3.14B3.37B
Gross Profit1.7B1.75B1.98B2.23B2.56B
Gross Margin42.4%40.3%41.3%41.6%43.2%
Research & Development00000
Selling, General & Admin228.5M209M258M266.5M295.2M
Operating Expenses1.04B1.12B1.25B1.37B1.51B
Depreciation & Amortization219.6M243.6M273.9M299.6M327.9M
EBITDA888.9M870.1M1.02B1.19B1.4B
EBITDA Margin22.1%20.0%21.3%22.1%23.7%
Operating Income659.4M630.2M731.8M864.5M1.05B
Operating Margin16.4%14.5%15.2%16.1%17.7%
Interest Income00000
Interest Expense164.3M175.7M143.5M137.4M123.2M
Other Income / Expenses(154.4M)(179.4M)(124.6M)(114.9M)(100.1M)
Income Before Tax505M450.8M607.2M749.6M953M
Pre-Tax Margin12.6%10.4%12.6%14.0%16.1%
Income Tax Expense101.9M100.1M132.2M150.2M192.9M
Net Income412.2M271M352M455.7M566.2M
Net Margin10.3%6.2%7.3%8.5%9.5%
EPS (Basic)4.152.723.544.535.62
EPS (Diluted)4.112.703.474.465.54
Weighted Avg Shares99M99.2M99.5M99.9M100.5M
Weighted Avg Shares (Diluted)100.2M100.4M101.3M102.2M102.2M

Encompass Health Corporation

NYSE:EHC

Intrinsic Alpha fair value

Locked

Current Price

$134.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.